Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Motley Fool Transcribing - ARS Pharma (SPRY) Q1 2026 Earnings Transcript
ARS Pharma (SPRY) Q1 2026 Earnings Transcript
The Motley Fool

Friday, May 15, 2026 at 8:30 a.m. ET Chief Executive Officer — Richard Lowenthal Chief Commercial Officer — Eric Karas Chief Financial Officer — Kathleen Scott Need a quote from a Motley Fool analyst? Email [email protected]…

zerohedge.com - Tyler Durden - Big Pharma RINO Bill Cassidy Smoked By Trump-Endorsed Candidate In Louisiana Senate Primary
Big Pharma RINO Bill Cassidy Smoked By Trump-Endorsed Candidate In Louisiana Senate Primary
Zero Hedge

Senator Bill Cassidy (R-LA) came in third in Louisiana's Republican Senate primary on Saturday - marking the first time in nearly 15 years that a sitting US Senator has lost a primary in a regularly scheduled election. Instead, Trump-endorsed Rep.

newswire.ca - Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development
Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development
CNW

Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra. Sofdra is the first and only FDA-approved new chemical entity…

newswire.ca - MS Pharma Announces Strategic Growth Investment from Olayan Financing Company
MS Pharma Announces Strategic Growth Investment from Olayan Financing Company
CNW

Strategic Partnership to Accelerate Growth in Saudi Arabia and Across the MENA Region AMMAN, Jordan and RIYADH, Saudi Arabia, May 18, 2026 /CNW/ -- MS Pharma today announced that Olayan Financing Company (OFC) has made a minority equity investment…

fool.com - Jonathan Ponciano - Boxer Capital's $18 Million Corvus Pharma Bet Signals Confidence in This Biotech's Next Phase
Boxer Capital's $18 Million Corvus Pharma Bet Signals Confidence in This Biotech's Next Phase
The Motley Fool

On May 15, 2026, Boxer Capital Management disclosed a new position in Corvus Pharmaceuticals (CRVS 9.85%), acquiring 1,100,000 shares in the first quarter for an estimated $17.55 million based on quarterly average pricing. According to a May 15…

thehindubusinessline.com - Strides Pharma Q4 profit jumps 51% at ₹129 cr
Strides Pharma Q4 profit jumps 51% at ₹129 cr
BusinessLine

Strides Pharma Science Ltd on Monday reported a 51 per cent rise in consolidated net profit at ₹129.28 crore for the fourth quarter ended March 31, 2026, driven by good growth in its main markets, excluding the US. The company had posted a…

cyprus-mail.com - LIFE Pharma-Detox project's pilot unit transferred to Medochemie's Dutch plant
LIFE Pharma-Detox project's pilot unit transferred to Medochemie's Dutch plant
Cyprus Mail

The pilot unit of the European LIFE Pharma-Detox project has been successfully transported to the Medochemie plant in the Netherlands, marking the start of the second phase of the project's pilot stage. The transfer of the unit to Medochemie's FAL…

statnews.com - Ed Silverman - U.K. advocacy groups threaten court action over a key provision in the pharma trade deal with the U.S.
U.K. advocacy groups threaten court action over a key provision in the pharma trade deal with the U.S.
STAT

Two advocacy groups are demanding the United Kingdom revoke regulations at the heart of a new trade agreement with the U.S. over concerns the deal will allow outsiders to influence official decisions about the cost-effectiveness of medicines. And…

rediff.com - Nandita Malik - Indian Stock Markets Recover Intraday Losses, IT Sector Leads Gains
Indian Stock Markets Recover Intraday Losses, IT Sector Leads Gains
Rediff.com

Indian stock markets demonstrated resilience by recovering significant intraday losses to close marginally higher, primarily propelled by robust value buying in the IT sector amidst global uncertainties and inflationary concerns. Indian benchmark…

indianexpress.com - Rahul Rao - Acutaas Chemicals: The specialty chemicals story the market is re-rating fast
Acutaas Chemicals: The specialty chemicals story the market is re-rating fast
The Indian Express

The key question is this: Is Acutaas Chemicals building a durable specialty chemicals franchise with multiple long-term growth engines? Or is the market extrapolating too much, too quickly, from a handful of high-growth verticals Understanding what…

thehindu.com - Pti - Stock markets end marginally higher on buying in IT counters
Stock markets end marginally higher on buying in IT counters
The Hindu

Benchmark indices Sensex and Nifty ended marginally higher on Monday (May 18, 2026) after facing sharp losses in intraday trade, supported by value buying in IT and select blue-chip counters. However, a weak rupee against the U.S. dollar and rising…

thehindubusinessline.com - Domestic drugmakers make a play for the innovation league
Domestic drugmakers make a play for the innovation league
BusinessLine

Barely two weeks apart, domestic drugmakers inked two major overseas transactions in the US. Sun Pharmaceuticals formalised an agreement for a $12 billion (₹1,14,000 crore) buy of Organon, whose product basket includes women's health and…

afaqs.com - afaqs! partner content - NewsReach wins Kaleido Award 2026 for Best Startup Campaign for Crafting Bharat Season 2, powered by AWS Startups
NewsReach wins Kaleido Award 2026 for Best Startup Campaign for Crafting Bharat Season 2, powered by AWS Startups
afaqs!

NewsReach, India's integrated PR and storytelling platform, has won the Best Startup Campaign award at the ET Kaleido Awards 2026 for Crafting Bharat Season 2, produced in partnership with AWS Startups. The recognition marks a significant moment…

globenewswire.com - Boehringer Ingelheim Limited - JASCAYD (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
JASCAYD (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
GlobeNewswire

Not intended for UK and US audiences JASCAYD (nerandomilast) now approved by Japan's MHLW for the treatment of adults with idiopathic pulmonary fibrosis and adults with progressive pulmonary fibrosis Approval enables access to the first oral PDE4B…

minnpost.com - Matthew Blake - Pharmaceutical lobbyists can pop the champagne: Minnesota 340B legislation fails to get House vote on Legislature's final day to pass bills
Pharmaceutical lobbyists can pop the champagne: Minnesota 340B legislation fails to get House vote on Legislature's final day to pass bills
MinnPost

The pharmaceutical industry won. The hospital industry lost. After a lobbying fight for the ages between the Pharmaceutical Researchers and Manufacturers of America and the Minnesota Hospital Association over a mysterious prescription drug discount…

Receive a Daily briefing on Pharma Industry News

Get Started